Injection and Non-Injection Drug Use Among Adults with Diagnosed HIV in the United States, 2015-2018

AIDS Behav. 2022 Apr;26(4):1026-1038. doi: 10.1007/s10461-021-03457-9. Epub 2021 Sep 18.

Abstract

Understanding behavioral characteristics and health outcomes of people with HIV (PWH) who inject drugs and PWH who use drugs, but do not inject, can help inform public health interventions and improve HIV clinical outcomes. However, recent, nationally representative estimates are lacking. We used 2015-2018 Medical Monitoring Project data to examine health outcome differences among adults with diagnosed HIV who injected drugs or who only used non-injection drugs in the past year. Data were obtained from participant interviews and medical record abstraction. We reported weighted percentages and prevalence ratios with predicted marginal means to assess differences between groups (P < 0.05). PWH who injected drugs were more likely to engage in high-risk sex; experience depression and anxiety symptoms, homelessness, and incarceration; and have lower levels of care retention, antiretroviral therapy adherence, and viral suppression. Tailored, comprehensive interventions are critical for improving outcomes among PWH who use drugs, particularly among those who inject drugs.

Keywords: HIV; HIV care continuum outcomes; People who inject drugs; People who use drugs; Social and structural factors.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • Humans
  • Ill-Housed Persons*
  • Prevalence
  • Retention in Care*
  • United States / epidemiology

Substances

  • Anti-Retroviral Agents